150 related articles for article (PubMed ID: 30342189)
1. The first-line antiepileptic drug carbamazepine: Reaction with biologically relevant free radicals.
Martins IL; Nunes J; Charneira C; Morello J; Pereira SA; Telo JP; Marques MM; Antunes AMM
Free Radic Biol Med; 2018 Dec; 129():559-568. PubMed ID: 30342189
[TBL] [Abstract][Full Text] [Related]
2. Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry.
Bu HZ; Zhao P; Dalvie DK; Pool WF
Rapid Commun Mass Spectrom; 2007; 21(20):3317-22. PubMed ID: 17879390
[TBL] [Abstract][Full Text] [Related]
3. Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s).
Madden S; Maggs JL; Park BK
Drug Metab Dispos; 1996 Apr; 24(4):469-79. PubMed ID: 8801063
[TBL] [Abstract][Full Text] [Related]
4. Mass Spectrometric Characterization of Circulating Covalent Protein Adducts Derived from Epoxide Metabolites of Carbamazepine in Patients.
Yip VLM; Meng X; Maggs JL; Jenkins RE; Marlot PT; Marson AG; Park BK; Pirmohamed M
Chem Res Toxicol; 2017 Jul; 30(7):1419-1435. PubMed ID: 28562019
[TBL] [Abstract][Full Text] [Related]
5. Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine.
Bu HZ; Kang P; Deese AJ; Zhao P; Pool WF
Drug Metab Dispos; 2005 Dec; 33(12):1920-4. PubMed ID: 16204461
[TBL] [Abstract][Full Text] [Related]
6. Metabolites and DNA-binding of carbamazepine and oxcarbazepine in vitro by rat liver microsomes.
Castrén K; Pienimäki P; Arvela P; Vähäkangas K
Hum Exp Toxicol; 1996 Jul; 15(7):577-82. PubMed ID: 8818711
[TBL] [Abstract][Full Text] [Related]
7. Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study.
Ghosh C; Hossain M; Spriggs A; Ghosh A; Grant GA; Marchi N; Perucca E; Janigro D
Epilepsia; 2015 Mar; 56(3):439-49. PubMed ID: 25656284
[TBL] [Abstract][Full Text] [Related]
8. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin.
Lu W; Uetrecht JP
Drug Metab Dispos; 2008 Aug; 36(8):1624-36. PubMed ID: 18463199
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine-Induced Liver Injury Requires CYP3A-Mediated Metabolism and Glutathione Depletion in Rats.
Iida A; Sasaki E; Yano A; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Drug Metab Dispos; 2015 Jul; 43(7):958-68. PubMed ID: 25870103
[TBL] [Abstract][Full Text] [Related]
10. A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain.
Ghosh C; Marchi N; Hossain M; Rasmussen P; Alexopoulos AV; Gonzalez-Martinez J; Yang H; Janigro D
Neurobiol Dis; 2012 Jun; 46(3):692-700. PubMed ID: 22426401
[TBL] [Abstract][Full Text] [Related]
11. Pathways of carbamazepine bioactivation in vitro: II. The role of human cytochrome P450 enzymes in the formation of 2-hydroxyiminostilbene.
Pearce RE; Uetrecht JP; Leeder JS
Drug Metab Dispos; 2005 Dec; 33(12):1819-26. PubMed ID: 16135660
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury.
Higuchi S; Yano A; Takai S; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
Toxicol Sci; 2012 Nov; 130(1):4-16. PubMed ID: 22790970
[TBL] [Abstract][Full Text] [Related]
13. High resolution mass spectrometry-based methodologies for identification of Etravirine bioactivation to reactive metabolites: In vitro and in vivo approaches.
Godinho ALA; Martins IL; Nunes J; Charneira C; Grilo J; Silva DM; Pereira SA; Soto K; Oliveira MC; Marques MM; Jacob CC; Antunes AMM
Eur J Pharm Sci; 2018 Jul; 119():70-82. PubMed ID: 29592839
[TBL] [Abstract][Full Text] [Related]
14. Covalent thiol adducts arising from reactive intermediates of cocaine biotransformation.
Schneider KJ; DeCaprio AP
Chem Res Toxicol; 2013 Nov; 26(11):1755-64. PubMed ID: 24112049
[TBL] [Abstract][Full Text] [Related]
15. N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7.
Staines AG; Coughtrie MW; Burchell B
J Pharmacol Exp Ther; 2004 Dec; 311(3):1131-7. PubMed ID: 15292462
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of carbamazepine by CYP3A6: a model for in vitro drug interactions studies.
Mesdjian E; Sérée E; Charvet B; Mirrione A; Bourgarel-Rey V; Desobry A; Barra Y
Life Sci; 1999; 64(10):827-35. PubMed ID: 10096433
[TBL] [Abstract][Full Text] [Related]
17. Reductive transformation of carbamazepine by abiotic and biotic processes.
König A; Weidauer C; Seiwert B; Reemtsma T; Unger T; Jekel M
Water Res; 2016 Sep; 101():272-280. PubMed ID: 27267475
[TBL] [Abstract][Full Text] [Related]
18. Effects of carbamazepine on hepatic glutathione level in rats and determination of carbamazepine and its epoxide metabolite in plasma by HPLC.
Yeşilaltay AK; Ersoy O; Omurtag GZ; Yurdun T
Drug Metabol Drug Interact; 1998; 14(4):251-8. PubMed ID: 10694932
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine 10, 11 epoxide concentrations in epileptics on carbamazepine alone and in combination with other anticonvulsants.
Brodie MJ; Forrest G; Rapeport WG
Br J Clin Pharmacol; 1983 Dec; 16(6):747-9. PubMed ID: 6661364
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the metabolites of carbamazepine in patient urine by liquid chromatography/mass spectrometry.
Maggs JL; Pirmohamed M; Kitteringham NR; Park BK
Drug Metab Dispos; 1997 Mar; 25(3):275-80. PubMed ID: 9172943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
